Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bicara Therapeutics Inc. - Common Stock
(NQ:
BCAX
)
16.88
+0.07 (+0.45%)
Streaming Delayed Price
Updated: 9:53 AM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,888
Open
16.77
Bid (Size)
16.52 (200)
Ask (Size)
16.80 (100)
Prev. Close
16.80
Today's Range
16.52 - 17.09
52wk Range
7.800 - 19.71
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12
December 15, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
December 06, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
-0.3%
-0.3%
1 Month
-9.1%
-9.1%
3 Month
+21.7%
+21.7%
6 Month
+81.6%
+81.6%
1 Year
-0.7%
-0.7%
More News
Read More
Bicara Therapeutics Announces Publication of an Abstract with Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab in 1L HPV-negative R/M HNSCC at ESMO Asia 2025
December 01, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
November 20, 2025
Via
Investor Brand Network
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
November 20, 2025
From
BioMedWire
Via
GlobeNewswire
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
Via
Investor Brand Network
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
Via
FinancialNewsMedia
These stocks that are showing activity before the opening bell on Monday.
↗
October 13, 2025
Via
Chartmill
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
October 13, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
4 Biotech Stocks Seeing Explosive Momentum Gains
↗
October 07, 2025
Via
Benzinga
Topics
ETFs
Stocks
Bicara Therapeutics to Participate in Upcoming Investor Conferences
August 27, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
June 11, 2025
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 04, 2025
Via
Benzinga
Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025
June 01, 2025
From
Bicara Therapeutics Inc.
Via
GlobeNewswire
Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?
↗
May 23, 2025
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
May 23, 2025
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 23, 2025
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
↗
May 23, 2025
Via
Chartmill
Gold Gains Over 1%; Ross Stores Shares Dip After Pulling Fiscal 2026 Outlook
↗
May 23, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
↗
May 23, 2025
Via
Chartmill
Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results
↗
May 23, 2025
Via
Benzinga
Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics
↗
May 23, 2025
Via
Investor's Business Daily
Frequently Asked Questions
Is Bicara Therapeutics Inc. - Common Stock publicly traded?
Yes, Bicara Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Bicara Therapeutics Inc. - Common Stock trade on?
Bicara Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bicara Therapeutics Inc. - Common Stock?
The ticker symbol for Bicara Therapeutics Inc. - Common Stock is BCAX on the Nasdaq Stock Market
What is the current price of Bicara Therapeutics Inc. - Common Stock?
The current price of Bicara Therapeutics Inc. - Common Stock is 16.88
When was Bicara Therapeutics Inc. - Common Stock last traded?
The last trade of Bicara Therapeutics Inc. - Common Stock was at 12/29/25 09:53 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
